Medizone International completes third round of testing and data logging for AsepticSure technology

NewsGuard 100/100 Score

Medizone International, Inc. (OTC Bulletin Board: MZEI.OB) announces that its third round of testing and data logging for the enhanced AsepticSure(TM) technology is now complete. Test results achieved over the past two months now predictably demonstrate greater than 6 logs of bacterial "kill" across the full spectrum of hospital contaminants including MRSA, C difficile, E coli, Pseudomonas aeruginosa and VRE in addition to the internationally accepted surrogate for Anthrax, Bacillus subtilis. Significantly, these results have been replicated on more than a single surface material. "This latest round of laboratory testing has confirmed beyond any reasonable doubt that our enhanced AsepticSure(TM) technology can reliably achieve sterilization standards for virtually any bacterial contaminant found in a hospital setting," stated Dr. Michael Shannon, Medizone's Director of Medical Affairs.

In related news, Medizone's full scale prototype unit has been completed and demonstrated in "dry" runs (bacteria free) that it can reach both the charge time and saturation requirements of its design criteria. The ability to replicate the exact atmosphere of the laboratory test unit in a full sized room is considered a crucial step in achieving the same 6 log bactericidal action in hospital settings.

SOURCE Medizone International, Inc.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
API processes in the pharmaceutical industry